You are viewing the site in preview mode
Skip to main content
| |
Vaccine
|
No Adjuvant
| |
|---|
| |
N = 67
|
N = 123
| |
|---|
| |
N(%)/Mean(SD)
|
N(%)/Mean(SD)
|
P-Value
|
|---|
|
Age
|
56.00 (13.44)
|
60.05 (16.44)
|
0.086
|
|
Sex
| | |
0.2854
|
|
Female
|
31 (46.27)
|
47 (38.21)
| |
|
Male
|
36 (53.73)
|
76 (61.79)
| |
|
Thicknessa
|
3.12 (4.43)
|
4.18 (4.46)
|
0.009
|
|
Ulceration
| | |
0.3511
|
|
Present
|
23 (34.33)
|
52 (42.28)
| |
|
Absent
|
32 (47.76)
|
57 (46.34)
| |
|
Undetermined
|
12 (17.91)
|
14 (11.38)
| |
|
AJCC Stage
| | |
0.0082
|
|
IIIA
|
15 (22.39)
|
48 (39.02)
| |
|
IIIB
|
26 (38.81)
|
51 (41.46)
| |
|
IIIC
|
26 (38.81)
|
24 (19.51)
| |
|
Histologic Subtype
| | |
0.0435
|
|
Nodular
|
17 (25.37)
|
52 (42.28)
| |
|
Superficial Spreading
|
12 (17.91)
|
26 (21.14)
| |
|
Other
|
6 (8.96)
|
13 (10.57)
| |
|
Undetermined
|
32 (47.76)
|
32 (26.02)
| |
|
Other Adjuvant Treatment
| | |
–
|
|
GM-CSF
|
6 (8.96)
|
Not Applicable
| |
|
Interferon
|
6 (8.96)
| |
|
Isolated Limb Infusion
|
3 (4.48)
| |
|
Radiation
|
22 (32.84)
| |
- amissing values for thickness: vaccine: 10; no adjuvant: 13
- athickness not normally-distributed, log-transformed for statistical test
